How the Body Heals Cancer

After three beats establishing what cancer is, how it develops, and how medicine compounds the damage, the reader arrives at the question that makes the entire preceding argument matter: what actually works? The answer Aajonus Vonderplanitz spent four decades developing is neither a drug nor a protocol in the pharmaceutical sense. It is a set of conditions. The body heals cancer the same way it heals everything else, by dissolving damaged tissue and eliminating it through its natural detoxification channels, and that process requires three things the modern cancer patient almost never has: a functional microbial workforce, adequate raw fat for buffering and solvent production, and open lymphatic drainage. The Primal Diet approach to cancer is not alternative treatment in the way that phrase is usually meant. It is terrain restoration, a systematic effort to recreate the biological conditions under which the body can complete the work it has already been attempting.

What Aajonus understood about cancer, and what the mainstream model has consistently refused to accommodate, is that a tumor is not the disease. It is the body's solution to a problem the disease created. When industrial chemicals, pharmaceutical residues, hydrogenated oils, and cooked-food debris accumulate faster than the lymphatic system can dissolve and eliminate them, cells die in quantities the body cannot process in real time. The dead cells cannot simply vanish. They have to go somewhere. So the body gathers them into a contained mass, a tumor, and holds them there until it can generate the biological resources necessary to dissolve them. As Aajonus stated plainly in one workshop: "Cancer is basically the body's inability to discard dead cells. The body gathers those cells in a particular area, called a tumor, until it can later dissolve those cells."

This framing is not merely rhetorical. It has structural consequences for how one approaches the condition. If the tumor is a storage depot rather than an invading force, then the therapeutic logic of attacking it is not just misguided but actively counterproductive. What the body needs is not an attack on the storage depot but the restoration of the biological infrastructure that would allow the depot to be emptied safely.

Thomas Seyfried's 2012 work, "Cancer as a Metabolic Disease," arrived at a related conclusion through the language of academic biochemistry. Seyfried argued that cancer is fundamentally a disorder of cellular energy metabolism, driven by damaged mitochondria rather than by random genetic mutations, and that the mutation-focused model has systematically misdirected both research and treatment. His framework, which places metabolic terrain at the center of cancer development, converges with Aajonus's clinical observations even though the two investigators were working from radically different methodological traditions. Both reached the same structural conclusion: the body's cellular environment, not the tumor cells themselves, is where the problem originates and where the solution must begin.

Of the three conditions the body requires to resolve cancer, raw fat is the most immediately critical, and it is the nutrient the modern diet has most systematically eliminated or corrupted. Aajonus was unequivocal on this point across decades of clinical documentation: "Raw fats dissolve and bind with dead cells and carry them from the body, or at least neutralize their toxicity, which helps stop tumor growth." This is not a vague claim about nutrition generally. It describes a specific biochemical function. When adequate raw fat circulates in the blood and tissues, it acts as both a buffer and a carrier: absorbing the toxic load that accumulates when dead cells are dissolved, protecting healthy surrounding tissue from the caustic byproducts of tumor dissolution, and providing the lymphatic system with the substrate it needs to produce biological solvents.

Without sufficient fat, those toxic substances do not simply stay in place. They migrate into the body's most vulnerable tissues, particularly the nervous system, the myelin sheaths, the brain, and the bone marrow, where they damage RNA and DNA and accelerate the very cell death that is feeding the tumor in the first place. The fat deficit is not a minor contributing factor. In Aajonus's clinical framework, it is the central mechanism by which cancer progresses.

The numbers Aajonus recommended were not modest. He documented advising cancer patients to accumulate significant body fat reserves, 23 pounds above normal weight for women and 35 pounds for men, because that stored fat is the buffer system for toxic dissolution. "Those fats are responsible for absorbing the toxins that are killing your cells," he explained. "If you have already collected a lot of cells, dead cells in the body, and you have cancer, you have to stop your body from collecting more." The logic is internally consistent: the worse the toxic accumulation, the greater the fat reserve needed to safely dissolve and eliminate it without the released poisons destroying healthy tissue in the process.

The specific raw fats Aajonus used therapeutically each had a distinct function. Raw cream, heavy and high in fat-soluble nutrients, feeds and nurtures the brain and nervous system, soothes tissue disturbed during toxic metal detoxification, and protects cells from mutation during periods of intense detox activity. Raw coconut cream, which is approximately 93 percent water-soluble fat, functions as what Aajonus called a "solvent-oriented fat," particularly effective for metal poisoning and for situations where bacterial function in the lymph has been compromised. He documented discovering, through trial and error with clients, that raw coconut cream was the safest and most efficient fat for expediting intense detoxification, and he consistently recommended consuming it alongside raw dairy cream so that the soothing and protective properties of the two fats could work in combination. Raw butter strengthens organs and glands and chelates toxic byproducts from tissues. Olive oil and flax oil, used in small amounts, function as solvents for dissolving accumulated toxicity.

The liver connects all of this. Aajonus found that in 90 percent of cancer cases, breakdown begins with hepatic compromise: the liver, overwhelmed by cooked fats laden with lipid oxides, loses its capacity to produce the range of cholesterol varieties the lymphatic system needs to dissolve dead cells. He documented that the liver produces approximately 60 varieties of cholesterol for three purposes: cleansing, energy, and protection. When the liver is compromised, cholesterol production narrows, the lymph system loses its solvent capacity, and dead cells begin to accumulate.

This reframes the cholesterol question in a way that directly contradicts standard oncological advice. On a raw fat diet, cholesterol levels often rise dramatically, sometimes to readings between 250 and 400 that would alarm any cardiologist. But Aajonus argued that this elevation, when produced by raw fats rather than oxidized cooked fats, is a positive clinical sign indicating that toxic cholesterol is being mobilized from tissues and is flowing through the blood toward elimination. Prescribing statins to lower cholesterol in cancer patients, which is standard practice when elevated readings appear during oncological care, further impairs the very detoxification system the body is using to survive. It removes the solvent infrastructure at exactly the moment the body is attempting to put it to work.

Research by Poff and colleagues, published in 2014 in PLoS ONE, provided independent metabolic support for the fat-based therapeutic model. Working in animal models, they demonstrated that ketogenic diets, high in fat and low in carbohydrate, enhanced the anti-tumor effects of metabolic therapies. The mechanism they identified, altering cellular energy substrate availability in ways that disadvantage cancer-associated metabolic dysfunction, is structurally compatible with Aajonus's clinical observations, even though his framework operates through lymphatic physiology rather than mitochondrial biochemistry. Both approaches converge on the same practical conclusion: fat-based nutrition supports the body's cancer-resolving mechanisms, and carbohydrate-heavy nutrition does not.

If raw fat is the solvent and the buffer, the microbial workforce is the labor force that actually performs the dissolution. Aajonus documented three mechanisms by which the body dissolves dead cells: bacterially, fungally, and through the viral-solvent activity of cancer cells themselves. The first is both the preferred and the cleanest pathway. Bacteria in a healthy body eat dead cells directly, and their waste products are largely recyclable, meaning the body can recover nutrients from the process rather than simply generating toxic debris.

The problem facing most cancer patients is that this workforce has been systematically decimated. Decades of antibiotic exposure, pharmaceutical drug history, and a diet of cooked and processed food that provides no living bacterial cultures have left the microbial ecosystem of the gut and lymph largely non-functional. Without bacteria to eat dead cells as they accumulate, the lymph system falls back on its own solvent production, and when that fails too, the body produces cancer cells as a last resort.

High meat, raw animal flesh that has been aged until it is dense with bacterial activity and enzymatic pre-digestion, is Aajonus's answer to microbial depletion. He documented that high meat provides fats and proteins in a form that is immediately bioavailable to the brain and nervous system, bypassing the digestive demands that raw meat in fresh form still requires. People consuming high meat often report increased energy, mental clarity, and mood improvement within minutes of eating it, a response Aajonus attributed to the immediate uptake of pre-digested neural nutrients.

For cancer patients specifically, the bacterial load in high meat represents something more than nutrition. It is workforce replacement. The bacteria in high meat are not foreign invaders but the same species that perform essential functions in the human gut and lymph. They arrive pre-digested and immediately bioavailable precisely because the fermentation process has already done the work that the patient's own digestive system can no longer perform reliably.

The objection that raw aged meat is dangerous because bacteria in food cause disease was addressed directly in the preceding chapter, but it is worth revisiting in the cancer context because the stakes are higher and the objection is more emotionally compelling. The germ theory framework, which this objection assumes, cannot explain why the same bacterial species that terrify food safety regulators are also the species performing essential detoxification functions in every healthy human gut. Aajonus's framework, consistent with the terrain model, holds that context determines outcome: bacteria in a depleted, toxic body may overwhelm compromised systems, while bacteria in a body being systematically nourished with raw fat and raw protein rebuild the workforce that was destroyed by the pharmaceutical history that preceded the cancer diagnosis.

Traditional cultures across the world consumed aged and fermented meats not as a matter of necessity but as medicinal staples, foods understood to confer specific physiological benefits that fresh meat did not provide in the same form. The Inuit consumed aged walrus meat. Central Asian cultures fermented mare's milk and aged raw meat as therapeutic foods. The tradition of fermented animal protein as medicine is as old as human culture itself. What Aajonus did was document the clinical outcomes of applying this tradition to cancer patients in a modern context, where the baseline microbial depletion was far more severe than any traditional population would have encountered.

The clinical data he accumulated was striking. While high-fat diets alone reversed cancer in approximately 60 percent of terminal cases, adding raw meats to the protocol raised that reversal rate to 96 to 98 percent. The difference between 60 percent and 97 percent is the microbial workforce. Fat provides the substrate; the bacteria do the work.

William Coley, working between 1893 and 1936, reached a structurally similar conclusion through a radically different methodology. A bone surgeon observing unexpected tumor regressions in patients who developed severe bacterial infections after surgery, Coley began deliberately inducing bacterial infections in cancer patients and documented substantial tumor regression rates across decades of clinical work. His preparations of killed bacterial cultures, which came to be known as Coley's toxins, activated the body's immune and microbial response in ways that modern immunology is only beginning to reconstruct. The mechanism, as Aajonus would have framed it, was the reactivation of the microbial workforce: the body, flooded with bacterial signal, redirected its resources toward the dissolution of dead tissue, and the tumors that had been accumulating that tissue began to shrink. The medical establishment ultimately marginalized Coley's work as the radiation and chemotherapy era took hold, but his clinical records, spanning thousands of patients, remain among the most extensive documentation of tumor regression outside pharmaceutical trials.

The third pillar of the terrain restoration framework is lymphatic drainage, and it is the most frequently overlooked because it involves no food at all. The lymphatic system is, in Aajonus's framework, the body's primary detoxification infrastructure: responsible for dissolving dead cells, processing the waste products of cellular breakdown, and delivering dissolved debris to the skin for elimination through perspiration. When this system is functioning, the body handles its dead-cell inventory continuously and quietly. When it is blocked, dead cells accumulate, tumors form, and the entire terrain shifts toward crisis.

The primary source of lymphatic blockage in modern bodies, Aajonus argued, is hydrogenated vegetable oil, which he insisted should be called by its accurate name: plastic oil. The hydrogenation process, which extends shelf life by converting liquid oils into semi-solid fats, produces what he described as waxy, hard material that lodges in the lymphatic channels and solidifies there. Because the lymphatic system derives 60 to 80 percent of its function from fats, and because those fats must remain fluid to do their work, plastic oils are uniquely destructive to lymphatic function. They do not flow; they congeal. They do not dissolve dead cells; they block the channels through which dissolution would otherwise occur.

For cancer patients whose lymphatic systems have been congested by years of processed food consumption, and further compromised in many cases by surgical lymph node removal during biopsy or staging procedures, reopening drainage is not optional. The raw fat protocol can produce the biological solvents; the microbial restoration can provide the workforce; but if the drainage channels remain blocked, the dissolved debris has nowhere to go, and the released toxins recirculate through the body rather than exiting through the skin.

Aajonus's answer to this was the hot bath protocol: baths lasting one to one and a half hours, taken every three to four days, hot enough to open the lymphatic channels, expand the tissue, and promote perspiration from the skin's surface. The mechanism is straightforward physiology. Heat increases circulation, expands the lymphatic vessels, and activates sweat glands, all of which accelerate the movement of dissolved lymphatic waste to the skin surface. For a body in active cancer dissolution, where the toxic load being processed is substantial, the bath protocol is not a comfort measure. It is the drainage infrastructure without which the entire dissolution process cannot complete.

When all three conditions are in place, a remarkable process unfolds that Aajonus documented extensively through clinical observation and, in earlier phases of his research, through direct examination of tumor tissue. A malignant tumor, unlike a benign one, has blood circulation running through it and contains live cancer cells interspersed among the dead cell mass. Those cancer cells are not, in his framework, the enemy. They are the body's final mechanism for completing the dissolution that the lymph system and the bacterial workforce could not accomplish on their own.

Each cancer cell holds within it a fluid that is viral in nature, a concentrated solvent capable of dissolving anywhere from 50 to 200 surrounding dead cells when released. When the cancer cell dies, it releases that serum into the tumor mass, and the dissolution that follows is rapid and chemically intensive. "That one cancer cell has enough fluid in it to dissolve 50 to 200 surrounding dead cells," Aajonus observed. "Now the waste of that is going to be highly poisonous and toxic." This is precisely why fat reserves matter so urgently: when a tumor begins to dissolve, the released material is a concentrated brew of whatever industrial chemicals killed the cells in the first place, and without adequate raw fat circulating in the blood and stored in the tissues, that material begins dissolving healthy cells along with the dead ones. The person without fat reserves does not heal; they are consumed by their own dissolution.

With adequate fat, the picture is entirely different. The released toxins are bound and buffered before they can damage surrounding tissue. The lymphatic system, flowing freely through clean channels, carries the waste to the skin. Perspiration eliminates it from the body. The tumor shrinks not because it was attacked but because its purpose was fulfilled: the dead cells it was holding have finally been dissolved, processed, and eliminated. The body did not need to be rescued from the tumor. It needed the resources to finish what the tumor was organizing.

Owanza, one of the case studies Aajonus documented at length in "We Want to Live," presented with 63 tumors. She rejected conventional treatment, followed the Primal Diet protocol, and experienced active dissolution so intense that she vomited up to 11 times daily during peak detoxification cycles lasting up to five weeks. The process took 11 years. At the end of it, she was alive, and she remained alive 24 years after that. The timeline is not one that the medical model would accept as a treatment outcome, partly because it cannot be packaged or patented and partly because it requires the patient to endure the healing process rather than suppressing it. But the outcome is terrain restoration: a body that has completed its own work rather than one that has been chemically stripped and left to manage the consequences.

The predictable objection to everything in this framework is the absence of clinical trials. There are no randomized controlled trials demonstrating that raw fat and high meat reverse cancer, and in the absence of such trials, the mainstream position is that the framework cannot be evaluated. This objection is not as neutral as it sounds. Clinical trials are designed around pharmaceutical interventions with isolated variables. A trial of terrain restoration would have to hold constant every variable in a person's diet, microbial environment, lifestyle, and toxic history simultaneously, which is not how trials are designed and not how whole-system biology works. The evidence base for Aajonus's framework is clinical observation across decades, case studies documented in sufficient detail to trace outcomes, and the kind of N-of-one testimony that medicine dismisses as anecdote until it has enough of them to call it a pattern. Aajonus documented reversal rates of 95 to 97 percent across thousands of cancer clients who did not receive conventional medical treatment. Absence of pharmaceutical-model evidence is not evidence of absence. It is a measurement problem, not a therapeutic one.

The objection that high meat is dangerous because bacteria cause food poisoning assumes the very framework that the terrain model dismantles. Bacteria in food are not inherently pathological. They become problematic in a body whose terrain cannot process them, which is exactly the condition that decades of antibiotic use and processed food consumption create. The bacteria in high meat are the same species that perform essential functions in a healthy gut; their arrival in pre-digested, immediately bioavailable form is precisely what makes them therapeutic rather than threatening for a body attempting to rebuild a depleted workforce.

The objection that telling cancer patients to eat fat contradicts established science is the most revealing of the three, because it shows how thoroughly the caloric model has displaced the terrain model in public and medical thinking. The claim that fat feeds cancer derives from caloric logic: fat is energy-dense, cancer cells consume energy, therefore fat feeds cancer. The terrain model does not operate in this framework at all. Raw fat binds with toxins, protects healthy cells from dissolved dead-cell waste, provides solvent substrate to the lymphatic system, and constitutes the single most important nutrient for a body attempting to dissolve accumulated dead tissue. These are not competing interpretations of the same data. They are answers to different questions, and the question the terrain model is answering, how does the body actually dissolve a tumor, is the one that matters.

Aajonus summarized the clinical record with characteristic directness: "95% of the people who come to me with cancer reverse it. And it's not me, it's the diet. I know what foods to eat to do it. And it's the foods that do it, not me." He was not claiming to be a healer. He was claiming to understand the conditions under which the body heals itself, and to have documented those conditions with enough consistency over enough time that the pattern is, by any reasonable evidentiary standard, compelling.

The framework is not comfortable. Eating raw fat in the quantities Aajonus recommended requires overriding decades of public health messaging. Consuming high meat requires a tolerance for the unfamiliar that most Western patients do not initially possess. Sitting in a hot bath for an hour and a half every few days while a tumor dissolves is an experience that has no cultural script to support it. The process is slow, sometimes painful, and does not come with the institutional reassurance that a hospital treatment provides. What it offers instead is the body doing its own work, on its own terms, with the resources it actually needs.

Cancer is the most extreme form of terrain collapse, the body's last resort when all other detoxification has failed. But most people do not reach cancer. They reach something quieter: a state where detoxification never completes, symptoms persist at low levels, and the body is neither healing nor dying, just stalled. This is chronic illness. And it may be more widespread than cancer itself.